Related Experiment Videos
[Chronic heart failure and osteoporosis]
Kardiologiia
|August 20, 2013
Summary
Osteoporosis and chronic heart failure share common risk factors and progression mechanisms, despite being historically viewed as independent conditions. Understanding these links is crucial for managing patient health and improving quality of life.
Area of Science:
- Gerontology
- Cardiology
- Endocrinology
Context:
- Osteoporosis and chronic heart failure are prevalent chronic diseases with significant complications impacting patient independence and quality of life.
- Historically considered separate conditions, emerging evidence highlights shared risk factors and pathophysiological pathways between osteoporosis and chronic heart failure.
- Effective management of these chronic diseases necessitates a comprehensive understanding of their interconnectedness.
Purpose:
- To explore the common mechanisms and risk factors underlying the development and progression of osteoporosis and chronic heart failure.
- To review current diagnostic methods for osteoporosis, including instrumental and laboratory assessments.
- To discuss the challenges and strategies for treating osteoporosis, particularly in the context of comorbid chronic heart failure.
Summary:
- Osteoporosis and chronic heart failure, both highly prevalent non-infectious diseases, share common risk factors and pathophysiological mechanisms.
- Complications like fractures in osteoporosis and decompensation in heart failure lead to reduced quality of life, hospitalization, and mortality.
- This review focuses on the interconnectedness of these conditions, their risk factors, diagnosis of osteoporosis, and treatment considerations.
Impact:
- Highlights the importance of considering osteoporosis in patients with chronic heart failure and vice versa.
- Provides insights into integrated management strategies for patients with both conditions.
- Aims to improve patient outcomes by addressing the shared underlying factors of osteoporosis and chronic heart failure.
Related Concept Videos
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...